Andrew received his first dose of hepatitis B vaccine
minutes after he was born. My intention had been to write an entry on hepatitis
B but, as you can see, I've had my hands full.
What we see is a sharp decrease in the incidence of
pertussis after the introduction of whole-cell pertussis vaccine in the
mid-1940's to the lowest point in 1976. Since then, there has been a gradual increase
in pertussis incidence.
In April of this year, Washington State Health Secretary
Mary Selecky declared that pertussis (whooping cough) had reached epidemic level in the state. At that time, 640
cases had been reported to the state Department of Health since the beginning
of the year.
Last Friday (July 20, 2012), the Centers for Disease Control and Prevention (CDC) published a summary of the current
pertussis epidemic in Washington State in the Morbidity and Mortality Weekly Report (MMWR). Between January 1st and June
16th, 2,520 cases had been reported – 13 times the number reported
during the same time last year. Illinois,
New York and Wisconsin
have also had dramatic increases in the numbers of pertussis cases compared to
last year. In fact, nearly half of all the states have reported more than
double the numbers of cases in the first six months of 2012 than their total
numbers of cases in 2011 (CDC, 2012a).
Overall, the national incidence
of pertussis is increasing. In 2011, a total of 8,284 cases of pertussis were
reported in the U.S. So far this year, 17,920 cases have been reported. One
notable exception is California. A total of 7,195 cases of pertussis were
reported during the 2010 epidemic in California. Last year 1,709 cases were
reported in California and, so far this year, 275 cases have been reported.
CDC, 2002 |
There are a number of factors that could be contributing to
the increase in the number of pertussis cases. One is simply that pertussis is
being recognized and diagnosed more frequently. Pertussis used to be thought of
as a childhood disease and immunity to pertussis was believed to be life-long.
We now know that immunity to pertussis wanes and that adults usually don’t have
the severe symptoms that are seen in children.
The epidemiological data from the current pertussis epidemic
in Washington State and the 2010 California epidemic suggests that immunity to
pertussis from acellular pertussis vaccines wanes more quickly than immunity
from whole-cell pertussis vaccines, which are no longer used in the U.S.
Whereas acellular pertussis vaccines contain up to 5 antigens,
whole-cell pertussis vaccines contained around 3,000 antigens. Whole-cell
vaccines are highly effective; unfortunately, they also have a high occurrence
of adverse events ("side effects"). Acellular vaccines have fewer
side effects and appear to be highly effective for the first two years after
immunization, but immunity seems to wane more quickly than after immunization
with a whole-cell pertussis vaccine.
So, why should my child or I receive a pertussis vaccine if
I can still get pertussis anyway? There are several reasons. Even though most
of the cases of pertussis are in vaccinated people, the attack ratio is much higher in unvaccinated people. Unvaccinated children are
eight times more likely to get pertussis than children who have received all of
the recommended doses of DTaP (CDC, 2012b).
Unvaccinated children with pertussis are more likely to have severe disease,
cough longer, and infect other people than vaccinated children (Baptista et al,
2006; Préziosi & Halloran, 2003; Tozzi et al., 2003).
No vaccine is 100% effective. We have known that immunity to
pertussis wanes, but it now appears that immunity from acellular vaccines wanes
more quickly than we thought. Nevertheless, acellular pertussis vaccines remain
our best defense against pertussis.
On a personal note, one of my duties as a nurse
epidemiologist in a county health department is to investigate cases of notifiable diseases. State law requires health care providers to report notifiable diseases to their local health jurisdiction (LHJ). Pertussis is one of those diseases. When the
health department receives notification of a case of pertussis, one of my
colleagues or I contact the parent of the child or the person with pertussis
and complete a case report form. We then submit the data that we collect to the Washington
State Department of Health and from there it is sent to the CDC. In this case,
the CDC published their analysis of Washington State pertussis data in the MMWR cited above.
In other words, the CDC report includes data that I collected.
References:
Águas, R., Gonçalves, G., & Gomes, G. M. G. (2006).
Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infectious Diseases, 6(2),
112-117. doi.org/10.1016/S1473-3099(06)70384-X.
Baptista, P. N., Magalhães, V., Rodrigues, L. C., Rocha, M.
A. W., & Pimentel, A. M. (2006). Pertussis vaccine effectiveness in
reducing clinical disease, transmissibility, and proportion of case with positive
culture after household exposure in Brazil. Pediatric
Infectious Disease Journal, 25(9), 844-846.
Centers for Disease Control and Prevention. (2002).
Pertussis – United States, 1997-2000. Morbidity
and Mortality Weekly Report, 51(4), 73-76. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5104a1.htm.
Centers for Disease Control and Prevention. (2012).
Notifiable diseases and mortality table. Morbidity
and Mortality Weekly Report, 61(28), ND-382-ND-395. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6128md.htm.
Center for Disease Control and Prevention. (2012). Pertussis
epidemic – Washington, 2012. Morbidity
and Mortality Weekly Report, 61(28), 517-522. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6128a1.htm.
Offit, P. A., Quarles, J., Gerber, M. A., Hackett, C. J.,
Marcuse, E. K., Kollman, T. R. et al. (2002). Addressing parents’ concerns: do
multiple vaccines overwhelm or weaken the infants immune system? Pediatrics, 109(1), 124-129. http://pediatrics.aappublications.org/content/109/1/124.full.
Préziosi, M-P. & Halloran, E. (2003). Effects of
pertussis vaccination on disease: vaccine efficacy in reducing clinical
severity. Clinical Infectious Diseases,
37(6), 772-779. http://cid.oxfordjournals.org/content/37/6/772.long.
Rohani, P. & Drake, J. M. (2011). The decline and
resurgence of pertussis in the US. Epidemics,
3(3-4), 183-188. doi: 10.1016/j.epidem.2011.10.001.
Tozzi, A. E., Ravá, L., Ciofi degli Atti, M. L., Salmaso,
S., Progetto Pertosse Working Group. (2003). Clinical presentation of pertussis
in unvaccinated and vaccinated children in the first six years of life. Pediatrics, 112(5), 1069-1075. http://pediatrics.aappublications.org/content/112/5/1069.full
Witt, M. A., Katz, P. H., & Witt, D. J. (2012).
Unexpectedly limited durability of immunity following acellular pertussis
vaccination in preadolescents in a North American outbreak. Clinical Infectious Diseases, 54(12),
1730-1735. doi: 10.1093/cid/cis287.